OpenStage · award
Helix Biotech Biosimilar mRNA Vaccines
Value£150k
Deadline—
Published4 Sept 2025
RegionNationwide
commercial.preparednessandcountermeasures@ukhsa.gov.uk
The procurement contact named on the official notice.
Sign up free to see how well this tender matches your company — the score, the signals that align, and where the gaps are.
Vaccine mimic materials-comprising messenger RNA (mRNA) and lipid nanoparticles (LNPs)-from Helix-Biotech.
Make the case to bid
Reveal who to approach at UK Health Security Agency, and generate a go-to-market strategy from their news, accounts and people.
- OCID
- ocds-h6vhtk-059422
- Stage
- award · Awarded
- Source
- Find a Tender
- Buyer ref
- 053931-2025
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Market context
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
UK Health Security Agency’s tender network
Assembling the network…